Other
2030
Medtronic 2030 increased by 0.1% to $1.35B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 10.1%, from $1.50B to $1.35B. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ3 2016
Last reportedQ3 2026Feb 24, 2026
How to read this metric
A stable or declining schedule of amortization supports long-term margin expansion.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2030. It provides a m...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_4a0a03Historical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.58B | $1.59B | $1.59B | $1.59B | $1.59B | $1.59B | $1.57B | $1.57B | $1.58B | $1.48B | $1.49B | $1.50B | $1.35B | $1.35B | $1.35B |
| QoQ Change | — | +0.6% | -0.1% | -0.2% | +0.1% | +0.2% | -1.6% | +0.3% | +0.3% | -6.5% | +0.8% | +0.7% | -10.2% | +0.1% | +0.1% |
| YoY Change | — | — | — | +0.4% | -0.2% | +0.1% | -1.3% | -1.1% | -0.9% | -5.9% | -5.4% | -5.1% | -8.9% | -9.5% | -10.1% |
Range$1.35B – $1.59B
CAGR-4.5%
Avg YoY Growth-4.0%
Median YoY Growth-3.2%
Current Streak2 quarters growth
2030 at Other Companies
Frequently Asked Questions
- What is Medtronic's 2030?
- Medtronic (MDT) reported 2030 of $1.35B in Q4 2025.
- How has Medtronic's 2030 changed year-over-year?
- Medtronic's 2030 decreased by 10.1% year-over-year, from $1.50B to $1.35B.
- What does 2030 mean?
- The expected non-cash expense for acquired intangible assets in the year 2030.